BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28059095)

  • 1. H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach.
    Kervarrec T; Collin C; Larousserie F; Bouvier C; Aubert S; Gomez-Brouchet A; Marie B; Miquelestorena-Standley E; Le Nail LR; Avril P; Christophe Pagès J; de Pinieux G
    Mod Pathol; 2017 Mar; 30(3):393-406. PubMed ID: 28059095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
    Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
    Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma.
    Amary MF; Berisha F; Mozela R; Gibbons R; Guttridge A; O'Donnell P; Baumhoer D; Tirabosco R; Flanagan AM
    Histopathology; 2016 Jul; 69(1):121-7. PubMed ID: 26844533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
    Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
    Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
    Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors.
    Nohr E; Lee LH; Cates JM; Perizzolo M; Itani D
    Hum Pathol; 2017 Oct; 68():119-127. PubMed ID: 28882701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
    Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
    Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone H3K36M mutation and trimethylation patterns in chondroblastoma.
    Lu C; Ramirez D; Hwang S; Jungbluth A; Frosina D; Ntiamoah P; Healey J; Zhu G; Chen W; Klein M; Hameed M
    Histopathology; 2019 Jan; 74(2):291-299. PubMed ID: 30098026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
    Shooshtarizadeh T; Rahimi M; Movahedinia S
    Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.
    Venneker S; Szuhai K; Hogendoorn PCW; Bovée JVMG
    Virchows Arch; 2020 Jan; 476(1):135-146. PubMed ID: 31728625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondroblastoma: An Update.
    Chen W; DiFrancesco LM
    Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of H3F3A p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR).
    Gamberi G; Morandi L; Benini S; Resca A; Cocchi S; Magagnoli G; Donati DM; Righi A; Gambarotti M
    Pathol Res Pract; 2018 Jan; 214(1):89-94. PubMed ID: 29254795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic lockdown of CDKN1A (p21) and CDKN2A (p16) characterises the neoplastic spindle cell component of giant cell tumours of bone.
    Giesche J; Mellert K; Geißler S; Arndt S; Seeling C; von Baer A; Schultheiss M; Marienfeld R; Möller P; Barth TF
    J Pathol; 2022 Aug; 257(5):687-696. PubMed ID: 35522566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.
    Lüke J; von Baer A; Schreiber J; Lübbehüsen C; Breining T; Mellert K; Marienfeld R; Schultheiss M; Möller P; Barth TFE
    Histopathology; 2017 Jul; 71(1):125-133. PubMed ID: 28211081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone Mutations and Bone Cancers.
    Taylor EL; Westendorf JJ
    Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histones and their practical application in bone tumors: Do I always need them?
    Reith JD
    Hum Pathol; 2024 May; 147():92-100. PubMed ID: 38307341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics.
    Guimarães LM; Baumhoer D; Andrei V; Friedel D; Koelsche C; Gomez RS; von Deimling A; Gomes CC
    J Pathol Clin Res; 2023 Nov; 9(6):464-474. PubMed ID: 37555357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.
    Behjati S; Tarpey PS; Presneau N; Scheipl S; Pillay N; Van Loo P; Wedge DC; Cooke SL; Gundem G; Davies H; Nik-Zainal S; Martin S; McLaren S; Goodie V; Robinson B; Butler A; Teague JW; Halai D; Khatri B; Myklebost O; Baumhoer D; Jundt G; Hamoudi R; Tirabosco R; Amary MF; Futreal PA; Stratton MR; Campbell PJ; Flanagan AM
    Nat Genet; 2013 Dec; 45(12):1479-82. PubMed ID: 24162739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of 36 cases of chondroblastomas: A single institutional experience.
    Rekhi B; Ghate S; Shah A; Ramadwar M; Gulia A
    Ann Diagn Pathol; 2020 Feb; 44():151440. PubMed ID: 31862519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma.
    Papke DJ; Hung YP; Schaefer IM; Bredella MA; Charville GW; Reith JD; Fletcher CDM; Nielsen GP; Hornick JL
    Mod Pathol; 2020 Nov; 33(11):2295-2306. PubMed ID: 32601382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.